WARNER-LAMBERT BENADRYL THIRD-QUARTER WORLDWIDE SALES RISE 42%
This article was originally published in The Tan Sheet
Executive Summary
WARNER-LAMBERT BENADRYL THIRD-QUARTER WORLDWIDE SALES RISE 42% to $44 mil. compared to the third quarter of 1993. Nearly all of Benadryl's sales, or $41.6 mil., were generated in the U.S. The growth of the Benadryl brand helped propel worldwide revenues for Warner-Lambert's Consumer Sector by 20% to $1.13 bil. during the three months ended Sept. 30.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning